These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 6227462
1. Factors influencing the host response to Leishmania mexicana. Pérez H. Ciba Found Symp; 1983; 99():157-73. PubMed ID: 6227462 [Abstract] [Full Text] [Related]
2. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity. Titus RG, Lima GC, Engers HD, Louis JA. J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088 [Abstract] [Full Text] [Related]
3. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH. Liew FY, Howard JG, Hale C. J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580 [Abstract] [Full Text] [Related]
4. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. Scott P, Pearce E, Natovitz P, Sher A. J Immunol; 1987 Jul 01; 139(1):221-7. PubMed ID: 3495599 [Abstract] [Full Text] [Related]
5. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection. Liew FY, Singleton A, Cillari E, Howard JG. J Immunol; 1985 Sep 01; 135(3):2102-7. PubMed ID: 3160786 [Abstract] [Full Text] [Related]
6. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells. Liew FY, Hale C, Howard JG. J Immunol; 1982 Apr 01; 128(4):1917-22. PubMed ID: 6120976 [Abstract] [Full Text] [Related]
7. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites. Liew FY, Dhaliwal JS. J Immunol; 1987 Jun 15; 138(12):4450-6. PubMed ID: 3295049 [Abstract] [Full Text] [Related]
8. Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania major-specific T cell lines or clones which secrete interferon-gamma and mediate parasite-specific delayed-type hypersensitivity. Titus RG, Müller I, Kimsey P, Cerny A, Behin R, Zinkernagel RM, Louis JA. Eur J Immunol; 1991 Mar 15; 21(3):559-67. PubMed ID: 1672641 [Abstract] [Full Text] [Related]
9. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states. Bretscher PA, Ogunremi O, Menon JN. Behring Inst Mitt; 1997 Feb 15; (98):153-9. PubMed ID: 9382736 [Abstract] [Full Text] [Related]
10. Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation. Basak SK, Saha B, Bhattacharya A, Roy S. Eur J Immunol; 1992 Aug 15; 22(8):2041-5. PubMed ID: 1386313 [Abstract] [Full Text] [Related]
11. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. Sacks DL, Scott PA, Asofsky R, Sher FA. J Immunol; 1984 Apr 15; 132(4):2072-7. PubMed ID: 6230400 [Abstract] [Full Text] [Related]
12. Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity. Saha B, Das G, Vohra H, Ganguly NK, Mishra GC. Eur J Immunol; 1995 Sep 15; 25(9):2492-8. PubMed ID: 7589116 [Abstract] [Full Text] [Related]
13. Adoptive transfer of delayed type hypersensitivity reactions specific for Leishmania major antigens to normal mice using murine T cell populations and clones generated in vitro. Lima GC, Engers HD, Louis JA. Clin Exp Immunol; 1984 Jul 15; 57(1):130-8. PubMed ID: 6204797 [Abstract] [Full Text] [Related]
14. Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells. Schrier RD, Ishioka GY, Pizer LI, Moorhead JW. J Immunol; 1985 May 15; 134(5):2889-93. PubMed ID: 2580006 [Abstract] [Full Text] [Related]
15. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice. Rosas LE, Keiser T, Barbi J, Satoskar AA, Septer A, Kaczmarek J, Lezama-Davila CM, Satoskar AR. Int Immunol; 2005 Oct 15; 17(10):1347-57. PubMed ID: 16141242 [Abstract] [Full Text] [Related]
16. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages. Prina E, Lang T, Glaichenhaus N, Antoine JC. J Immunol; 1996 Jun 01; 156(11):4318-27. PubMed ID: 8666803 [Abstract] [Full Text] [Related]
17. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major. Doherty TM, Coffman RL. J Immunol; 1993 Jun 15; 150(12):5476-83. PubMed ID: 8515072 [Abstract] [Full Text] [Related]
18. Recognition of protozoan parasites by murine T lymphocytes. II. Role of the H-2 gene complex in interactions between antigen-presenting macrophages and Leishmania-immune T lymphocytes. Louis JA, Moedder E, MacDonald HR, Engers HD. J Immunol; 1981 May 15; 126(5):1661-6. PubMed ID: 6452473 [Abstract] [Full Text] [Related]
19. Analysis of variables associated with promotion of resistance and its abrogation in T cell-reconstituted nude mice infected with Leishmania major. Moll H, Mitchell GF. J Parasitol; 1988 Dec 15; 74(6):993-8. PubMed ID: 3264023 [Abstract] [Full Text] [Related]
20. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40. Hernández MX, Barçante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ. Immunol Lett; 2006 May 15; 105(1):38-47. PubMed ID: 16466810 [Abstract] [Full Text] [Related] Page: [Next] [New Search]